Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Chipscreen Biosciences, Ltd. clinical trials
The registry lists 42 studies whose lead sponsor is Chipscreen Biosciences, Ltd.. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Chipscreen Biosciences, Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Chipscreen Biosciences, Ltd..
- Chipscreen Biosciences, Ltd.42 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 42 of 42.
- Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeRecruitingNCT06947967Phase 3
- A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and LymphomaNot yet recruitingNCT07583771Phase 1
- Chiglitazar Added to SGLT-2 Inhibitors for Type 2 DiabetesNot yet recruitingNCT07580638
- A Study of CS23546 in Subjects With Advanced TumorsRecruitingNCT06245122Phase 1
- Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release TabletsNot yet recruitingNCT07511010Phase 1
- A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer PatientsRecruitingNCT06497985Phase 3
- Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07445295Phase 3
- A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT07129382Phase 1/2
- Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid TumorsRecruitingNCT06902350Phase 1
- Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian CancerRecruitingNCT04921527Phase 3
- A Study of NWY001 in Subjects With Advanced Solid TumorsRecruitingNCT05979155Phase 1
- Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.RecruitingNCT05271292Phase 1/2
- Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaActive, not recruitingNCT06492915Phase 2
- Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release TabletsCompletedNCT07412015Not applicable
- Bioequivalence Study of Chiglitazar/Metformin Extended-Release TabletsCompletedNCT07519265Not applicable
- A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLCCompletedNCT05519865Phase 2
- Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCLCompletedNCT04231448Phase 3
- Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)CompletedNCT05497843Phase 2
- A Phase II Study of Chiauranib in Combine With Capecitabine in TNBCTerminatedNCT05336721Phase 2
- Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung CancerCompletedNCT04830813Phase 3
- A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 CapsulesCompletedNCT06224595Phase 1
- Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.CompletedNCT05068427Phase 2
- Chiglitazar Added to Metformin for Type 2 DiabetesCompletedNCT04807348Phase 3
- Mass Balance Study of [14C]ChiauranibCompletedNCT05371899Not applicable
- Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal FunctionCompletedNCT05515458Phase 1
- A Phase II Clinical Trial of Chiglitazar for NASHCompletedNCT05193916Phase 2
- Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT05515445Phase 1
- A Clinical Trial of CS12192 in Healthy SubjectsCompletedNCT05922709Phase 1
- Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung CancerCompletedNCT03216343Phase 1
- Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.CompletedNCT05681273Phase 1
- Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy VolunteersCompletedNCT05346601Phase 1
- Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's LymphomaCompletedNCT03974243Phase 1/2
- Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02482753Phase 3
- Study of Chiauranib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT03245190Phase 1/2
- Chiauranib in Combination With Chemotherapy in Patients With Ovarian CancerCompletedNCT03901118Phase 2
- Phase Ib Study of Chiauranib in Patients With Ovarian CancerCompletedNCT03166891Phase 1/2
- Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes PatientsCompletedNCT02173457Phase 3
- Study of Chiglitazar Compare With Placebo in Type 2 Diabetes PatientsCompletedNCT02121717Phase 3
- Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma PatientsCompletedNCT02809573Phase 1
- Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's LymphomaTerminatedNCT03074825Phase 1
- Phase I Study of Chiauranib in Patients With Advanced Solid TumorsCompletedNCT02122809Phase 1
- Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT01836679Phase 2